This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Mesenchymal stem cell-based therapy for autoimmune-related fibrotic skin diseases—systemic sclerosis and sclerodermatous graft-versus-host disease
Stem Cell Research & Therapy Open Access 18 December 2023
-
The Therapeutic Effects of Exosomes Derived from Human Umbilical Cord Mesenchymal Stem Cells on Scleroderma
Tissue Engineering and Regenerative Medicine Open Access 16 November 2021
-
Mechanisms utilized by feline adipose-derived mesenchymal stem cells to inhibit T lymphocyte proliferation
Stem Cell Research & Therapy Open Access 25 June 2019
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Le Blanc K, Rasmusson I, Sundberg B, Gotherstrom C, Hassan M, Uzunel M et al. Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells. Lancet 2004; 363: 1439–1441.
Zappia E, Casazza S, Pedemonte E, Benvenuto F, Bonanni I, Gerdoni E et al. Mesenchymal stem cells ameliorate experimental autoimmune encephalomyelitis inducing T-cell anergy. Blood 2005; 106: 1755–1761.
Devine SM, Bartholomew AM, Mahmud N, Nelson M, Patil S, Hardy W et al. Mesenchymal stem cells are capable of homing to the bone marrow of non-human primates following systemic infusion. Exp Hematol 2001; 29: 244–255.
Sun Y, Chen HM, Subudhi SK, Chen J, Koka R, Chen L et al. Costimulatory molecule-targeted antibody therapy of a spontaneous autoimmune disease. Nat Med 2002; 8: 1405–1413.
Le Blanc K, Gotherstrom C, Ringden O, Hassan M, McMahon R, Horwitz E et al. Fetal mesenchymal stem-cell engraftment in bone after in utero transplantation in a patient with severe osteogenesis imperfecta. Transplantation 2005; 79: 1607–1614.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Christopeit, M., Schendel, M., Föll, J. et al. Marked improvement of severe progressive systemic sclerosis after transplantation of mesenchymal stem cells from an allogeneic haploidentical-related donor mediated by ligation of CD137L. Leukemia 22, 1062–1064 (2008). https://doi.org/10.1038/sj.leu.2404996
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.leu.2404996
This article is cited by
-
Mesenchymal stem cell-based therapy for autoimmune-related fibrotic skin diseases—systemic sclerosis and sclerodermatous graft-versus-host disease
Stem Cell Research & Therapy (2023)
-
Progress in research on mesenchymal stem cells and their extracellular vesicles for treating fibrosis in systemic sclerosis
Clinical and Experimental Medicine (2023)
-
Formulation of secretome derived from mesenchymal stem cells for inflammatory skin diseases
Journal of Pharmaceutical Investigation (2023)
-
Combining systemic and locally applied cellular therapies for the treatment of systemic sclerosis
Bone Marrow Transplantation (2022)
-
The Therapeutic Effects of Exosomes Derived from Human Umbilical Cord Mesenchymal Stem Cells on Scleroderma
Tissue Engineering and Regenerative Medicine (2022)